Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012725 |
---|---|
Receipt number | R000014866 |
Scientific Title | Phase II study of neoadjuvant erlotinib in patients with stage III-N2 non-small cell lung cancer with EGFR mutations |
Date of disclosure of the study information | 2014/01/02 |
Last modified on | 2013/12/29 14:50:42 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/29 14:52:24 |